Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ladan Mm"'
Publikováno v:
Innovative Energy & Research.
The waste snail shell was screened to determine its efficiency as heterogeneous catalyst for biodiesel production via trans-esterification reaction. Prior to its use, the solid oxide material (shell) was calcined at 800°C for 4 h to convert CaCO3 to
Autor:
Suleiman MA; Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna, Nigeria., Abdulwase I; Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna, Nigeria., Tukur KA; Dialogue Pharmacy Limited, Isa kaita Road, Kaduna, Nigeria., Umar ZB; Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna, Nigeria., Muhammad SS; Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna, Nigeria., Ladan MM; Wolfson Institute of Population Health, Queen Mary University of London, Floyer House Philpot Street, London E1 2DP, United Kingdom., Muhammad M; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria., Hussaini F; Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna, Nigeria.
Publikováno v:
Exploratory research in clinical and social pharmacy [Explor Res Clin Soc Pharm] 2023 Oct 01; Vol. 12, pp. 100341. Date of Electronic Publication: 2023 Oct 01 (Print Publication: 2023).
Autor:
Ladan MM; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Rotterdam, The Netherlands., Meijer TG; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Rotterdam, The Netherlands., Verkaik NS; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Rotterdam, The Netherlands., de Monye C; Department of Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Koppert LB; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Kanaar R; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Rotterdam, The Netherlands., Nonnekens J; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Rotterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Gent DC; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. a.jager@erasmusmc.nl.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2023 Sep 30; Vol. 9 (1), pp. 80. Date of Electronic Publication: 2023 Sep 30.
Autor:
Meijer TG; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. t.meijer@erasmusmc.nl.; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. t.meijer@erasmusmc.nl.; Oncode Institute, Utrecht, The Netherlands. t.meijer@erasmusmc.nl., Nguyen L; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Van Hoeck A; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Verkaik NS; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Ladan MM; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Ruigrok-Ritstier K; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van de Werken HJG; Cancer Computational Biology Center, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Lips EH; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands., Memari Y; Academic Department of Medical Genetics, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Davies H; Academic Department of Medical Genetics, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Nik-Zainal S; Academic Department of Medical Genetics, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Kanaar R; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Cuppen E; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.; Science Park, Hartwig Medical Foundation, Amsterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Gent DC; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
Publikováno v:
Oncogene [Oncogene] 2022 Jun; Vol. 41 (26), pp. 3498-3506. Date of Electronic Publication: 2022 Jun 03.
Autor:
Ladan MM; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands., Meijer TG; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands., Verkaik NS; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands., Komar ZM; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute, 3000 CA Rotterdam, The Netherlands., den Bakker MA; Department of Pathology, Maasstad Ziekenhuis, 3007 AC Rotterdam, The Netherlands., Kanaar R; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands., van Gent DC; Department of Molecular Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, 3000 CA Rotterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Feb 28; Vol. 14 (5). Date of Electronic Publication: 2022 Feb 28.
Autor:
Ladan MM; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands., van Gent DC; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Feb 28; Vol. 13 (5). Date of Electronic Publication: 2021 Feb 28.